首页 > 最新文献

Clinical Neuropathology最新文献

英文 中文
Clinical Neuropathology 3-2022. 临床神经病理学3-2022。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-04-25 DOI: 10.5414/NPP41095
I. Fischer, J. Hainfellner
{"title":"Clinical Neuropathology 3-2022.","authors":"I. Fischer, J. Hainfellner","doi":"10.5414/NPP41095","DOIUrl":"https://doi.org/10.5414/NPP41095","url":null,"abstract":"","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43980842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obituary for Dr. Paul Kleihues (1936 - 2022). 保罗·克莱修斯博士(1936 - 2022)的讣告。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-04-25 DOI: 10.5414/NP301486
H. Ohgaki, J. Hainfellner
{"title":"Obituary for Dr. Paul Kleihues (1936 - 2022).","authors":"H. Ohgaki, J. Hainfellner","doi":"10.5414/NP301486","DOIUrl":"https://doi.org/10.5414/NP301486","url":null,"abstract":"","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42874157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the NF2:c.784C>T p.(Arg262*) variant. 一名携带NF2:c.784C>T.p.(Arg262*)变体的2型马赛克神经纤维瘤病患者对贝伐单抗的持续反应。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-04-21 DOI: 10.5414/NP301464
Elena Basenach, Alisa Förster, P. Raab, Samer Alzein, Gunnar Schmidt, J. Krauss, B. Schlegelberger, F. Heidenreich, B. Auber, C. Hartmann, B. Wiese, R. Weber
Neurofibromatosis type 2 (NF2) is a tumor predisposition syndrome characterized by the growth of schwannomas, especially bilateral vestibular schwannomas (VS), meningiomas, and ependymomas. The anti-VEGF antibody bevacizumab has shown efficacy for VS in some NF2 patients. However, there is limited data on the effect of bevacizumab on non-vestibular tumors, and on the correlation between therapy response and genotype. Here, we report on a 33-year-old patient with bilateral VS, 14 additional intracranial or spinal schwannomas, and a meningioma treated with bevacizumab, off-label in the European Union, for 2 years. The genotype of the patient was determined by mutational analysis of NF2, SMARCB1, and LZTR1 on DNA of multiple tissues. Additionally, we performed volumetric measurements of quantifiable non-vestibular tumors (n = 8) on MRI scans from 5 pre-therapeutic and 2 therapeutic years, and pure-tone audiometry of the non-deaf ear. A heterozygous NM_000268.3(NF2):c.784C>T p.(Arg262*) variant was identified in DNA from 3 schwannomas, but not in leukocyte or oral mucosa DNA, and no rare SMARCB1/LZTR1 variants were detected, establishing the diagnosis of definite NF2 mosaicism. While schwannomas had progressed with a mean annual growth rate of 38% pre-therapeutically, volume stabilization or reduction of all schwannomas along with improvement of pain and neurological deficits, including hearing impairment, were observed under 24 months of bevacizumab. In summary, this is the first report of a sustained response to bevacizumab in a patient shown to carry the frequent mosaic NF2:c.784C>T p.(Arg262*) variant. Our results may be of particular relevance to guide treatment decisions in mosaic NF2 patients harboring this variant.
2型神经纤维瘤病(NF2)是一种以神经鞘瘤生长为特征的肿瘤易感综合征,尤其是双侧前庭神经鞘瘤(VS)、脑膜瘤和室管膜瘤。抗VEGF抗体贝伐单抗在一些NF2患者中显示出对VS的疗效。然而,关于贝伐单抗对非前庭肿瘤的影响,以及治疗反应与基因型之间的相关性,数据有限。在此,我们报告了一名33岁的双侧VS患者,14例额外的颅内或脊椎神经鞘瘤,以及一例在欧盟接受非标签贝伐单抗治疗2年的脑膜瘤。通过对多个组织的DNA上的NF2、SMARCB1和LZTR1的突变分析来确定患者的基因型。此外,我们在治疗前5年和治疗后2年的MRI扫描中对可量化的非前庭肿瘤(n=8)进行了体积测量,并对非聋耳进行了纯音测听。在3例神经鞘瘤的DNA中发现了一个杂合子NM_000268.3(NF2):c.784C>T.p.(Arg262*)变体,但在白细胞或口腔粘膜DNA中没有发现,并且没有检测到罕见的SMARCB1/LZTR1变体,从而确定了NF2嵌合体的诊断。虽然神经鞘瘤在治疗前以38%的年平均增长率发展,但在贝伐单抗治疗24个月后,观察到所有神经鞘瘤的体积稳定或减少,同时疼痛和神经功能缺损(包括听力损伤)得到改善。总之,这是第一份显示携带频繁马赛克NF2:c.784C>T.p.(Arg262*)变体的患者对贝伐单抗有持续反应的报告。我们的研究结果可能对指导携带该变体的马赛克NF2患者的治疗决策具有特别的相关性。
{"title":"Sustained response to bevacizumab in a patient with mosaic neurofibromatosis type 2 carrying the NF2:c.784C>T p.(Arg262*) variant.","authors":"Elena Basenach, Alisa Förster, P. Raab, Samer Alzein, Gunnar Schmidt, J. Krauss, B. Schlegelberger, F. Heidenreich, B. Auber, C. Hartmann, B. Wiese, R. Weber","doi":"10.5414/NP301464","DOIUrl":"https://doi.org/10.5414/NP301464","url":null,"abstract":"Neurofibromatosis type 2 (NF2) is a tumor predisposition syndrome characterized by the growth of schwannomas, especially bilateral vestibular schwannomas (VS), meningiomas, and ependymomas. The anti-VEGF antibody bevacizumab has shown efficacy for VS in some NF2 patients. However, there is limited data on the effect of bevacizumab on non-vestibular tumors, and on the correlation between therapy response and genotype. Here, we report on a 33-year-old patient with bilateral VS, 14 additional intracranial or spinal schwannomas, and a meningioma treated with bevacizumab, off-label in the European Union, for 2 years. The genotype of the patient was determined by mutational analysis of NF2, SMARCB1, and LZTR1 on DNA of multiple tissues. Additionally, we performed volumetric measurements of quantifiable non-vestibular tumors (n = 8) on MRI scans from 5 pre-therapeutic and 2 therapeutic years, and pure-tone audiometry of the non-deaf ear. A heterozygous NM_000268.3(NF2):c.784C>T p.(Arg262*) variant was identified in DNA from 3 schwannomas, but not in leukocyte or oral mucosa DNA, and no rare SMARCB1/LZTR1 variants were detected, establishing the diagnosis of definite NF2 mosaicism. While schwannomas had progressed with a mean annual growth rate of 38% pre-therapeutically, volume stabilization or reduction of all schwannomas along with improvement of pain and neurological deficits, including hearing impairment, were observed under 24 months of bevacizumab. In summary, this is the first report of a sustained response to bevacizumab in a patient shown to carry the frequent mosaic NF2:c.784C>T p.(Arg262*) variant. Our results may be of particular relevance to guide treatment decisions in mosaic NF2 patients harboring this variant.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49569661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of pituitary adenoma with infiltration into the sphenoid sinus accompanied by melanocyte proliferation. 垂体腺瘤浸润蝶窦并伴有黑素细胞增殖1例。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-04-21 DOI: 10.5414/NP301436
Toshiyuki Enomoto, M. Aoki, M. Takahara, Masani Nonaka, H. Abe, C. Inomoto, Tooru Inoue, K. Nabeshima
A 71-year-old woman presenting with headache and nausea was admitted to hospital. Magnetic resonance imaging revealed a tumorous lesion that surrounded the sella turcica and infiltrated the sphenoid sinus with bone destruction. The tumor was removed by nasal endoscopy. The histology was consistent with pituitary adenoma; immunohistochemistry indicated silent corticotroph adenoma with melanocyte proliferation. The possibility that melanocytes were incorporated into the tumor mass in the sphenoid sinus and underwent proliferation was evaluated by investigating the mechanisms of melanocyte proliferation associated with basic fibroblast growth factor (bFGF) and α melanocyte-stimulating hormone (αMSH). In the normal tissue, the pars intermedia and adrenocorticotropic hormone (ACTH)-producing cells were positive for αMSH. None of the control adenoma tissues were positive for bFGF or αMSH by immunostaining. In the present case, bFGF-positive cells and αMSHpositive cells were observed, suggesting that both may have been involved in melanocyte proliferation. The expression of bFGF has been linked to aggressive disease. Pituitary adenoma with melanocyte proliferation has not been previously reported. Careful follow-up is deemed necessary in the future.
一名71岁妇女因头痛和恶心入院。磁共振成像显示肿瘤病变包围蝶鞍并浸润蝶窦伴骨破坏。经鼻内镜切除肿瘤。组织学符合垂体腺瘤;免疫组化示无症状促皮质腺瘤伴黑素细胞增生。通过研究黑素细胞增殖与碱性成纤维细胞生长因子(bFGF)和α促黑素细胞激素(α msh)相关的机制,评估黑素细胞被纳入蝶窦肿瘤肿块并进行增殖的可能性。正常组织中,促肾上腺皮质激素(ACTH)产生细胞α - msh阳性。对照腺瘤组织均未见bFGF或α - msh免疫染色阳性。在本病例中,观察到bfgf阳性细胞和α msh阳性细胞,提示两者都可能参与了黑素细胞的增殖。bFGF的表达与侵袭性疾病有关。垂体腺瘤伴黑素细胞增生尚未见报道。今后有必要进行仔细的随访。
{"title":"A case of pituitary adenoma with infiltration into the sphenoid sinus accompanied by melanocyte proliferation.","authors":"Toshiyuki Enomoto, M. Aoki, M. Takahara, Masani Nonaka, H. Abe, C. Inomoto, Tooru Inoue, K. Nabeshima","doi":"10.5414/NP301436","DOIUrl":"https://doi.org/10.5414/NP301436","url":null,"abstract":"A 71-year-old woman presenting with headache and nausea was admitted to hospital. Magnetic resonance imaging revealed a tumorous lesion that surrounded the sella turcica and infiltrated the sphenoid sinus with bone destruction. The tumor was removed by nasal endoscopy. The histology was consistent with pituitary adenoma; immunohistochemistry indicated silent corticotroph adenoma with melanocyte proliferation. The possibility that melanocytes were incorporated into the tumor mass in the sphenoid sinus and underwent proliferation was evaluated by investigating the mechanisms of melanocyte proliferation associated with basic fibroblast growth factor (bFGF) and α melanocyte-stimulating hormone (αMSH). In the normal tissue, the pars intermedia and adrenocorticotropic hormone (ACTH)-producing cells were positive for αMSH. None of the control adenoma tissues were positive for bFGF or αMSH by immunostaining. In the present case, bFGF-positive cells and αMSHpositive cells were observed, suggesting that both may have been involved in melanocyte proliferation. The expression of bFGF has been linked to aggressive disease. Pituitary adenoma with melanocyte proliferation has not been previously reported. Careful follow-up is deemed necessary in the future.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48240247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intracerebral retina-like pigmented tissue in a stillborn fetus with holoprosencephaly. 无前脑畸形死胎的脑内视网膜样色素组织。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-04-01 DOI: 10.5414/NP301453
Hao Li, Qi Zhang, L. Ang
A stillbirth fetus with semilobar holoprosencephaly was induced at 24 weeks gestational age. While the eyes appeared unremarkable externally, there was an absence of optic nerves. At the ventral hypothalamicdiencephalic region there was an area of bilateral epithelioid cells containing melanin. Immunohistochemical characterization revealed the cells to be of neuroepithelial origin with features of retinal pigment epithelium. These findings reflect abnormalities in eye development in holoprosencephaly, especially when coupled with other structural defects in the visual system.
在24周孕龄时引产半叶前脑畸形死产胎儿。虽然他的眼睛外表看起来没什么特别之处,但却没有视神经。下丘脑间脑区腹侧可见双侧含有黑色素的上皮样细胞区。免疫组织化学鉴定显示细胞为神经上皮细胞,具有视网膜色素上皮的特征。这些发现反映了无前脑畸形的眼睛发育异常,特别是当加上视觉系统的其他结构缺陷时。
{"title":"Intracerebral retina-like pigmented tissue in a stillborn fetus with holoprosencephaly.","authors":"Hao Li, Qi Zhang, L. Ang","doi":"10.5414/NP301453","DOIUrl":"https://doi.org/10.5414/NP301453","url":null,"abstract":"A stillbirth fetus with semilobar holoprosencephaly was induced at 24 weeks gestational age. While the eyes appeared unremarkable externally, there was an absence of optic nerves. At the ventral hypothalamicdiencephalic region there was an area of bilateral epithelioid cells containing melanin. Immunohistochemical characterization revealed the cells to be of neuroepithelial origin with features of retinal pigment epithelium. These findings reflect abnormalities in eye development in holoprosencephaly, especially when coupled with other structural defects in the visual system.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47282122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recurrent cerebellar liponeurocytoma with anaplastic features at initial presentation: A case report. 初次出现时具有间变性特征的复发性小脑脂肪神经细胞瘤:一例报告。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-03-28 DOI: 10.5414/NP301403
M. Maharaj, S. Tawfik, F. Ziad, T. Muthu
BACKGROUNDCerebellar liponeurocytoma is a rare entity with fewer than 100 reported cases and series in the available literature to date. Although the cerebellum remains the typical primary site, the entity has been shown to demonstrate increased aggressiveness and malignant progression with multiple recurrences.CASE DESCRIPTIONWe present a unique case in a 64-year-old gentleman of a cerebellar liponeurocytoma with multiple recurrences and progressive anaplasia. The tumor showed anaplastic features at first presentation and recurred in a more aggressive fashion in a short 2-year period despite surgical debulking and post-operative radiotherapy. It re-recurred within 6 months with subsequent re-debulking without further radiotherapy. At latest follow-up almost 3 years since surgical management of the patient's second recurrence, the patient remains well with minimal neurological impairment and no radiological signs of recurrence.CONCLUSIONCerebellar liponeurocytoma may present with increasingly atypical histological features that may warrant more aggressive post-operative treatment to prevent disease recurrence and clinical deterioration. This may include a more aggressive surgical resection margin and consideration of adjuvant radiotherapy in all cases.
背景小脑脂肪神经细胞瘤是一种罕见的实体瘤,迄今为止,在现有文献中报告的病例和系列不到100例。尽管小脑仍然是典型的原发部位,但该实体已被证明具有增强的侵袭性和恶性进展,并伴有多次复发。病例描述我们报告了一个独特的病例,一位64岁的绅士患有小脑脂肪神经细胞瘤,伴有多次复发和进行性发育不良。肿瘤在第一次出现时表现出间变性特征,尽管进行了手术切除和术后放疗,但在短短2年内以更具侵袭性的方式复发。它在6个月内再次复发,随后在没有进一步放疗的情况下再次揭穿。在对患者第二次复发进行手术治疗近3年后的最新随访中,患者保持良好,神经损伤最小,没有复发的放射学迹象。结论小脑脂肪神经细胞瘤可能表现出越来越不典型的组织学特征,这可能需要更积极的术后治疗来防止疾病复发和临床恶化。这可能包括更积极的手术切除范围,并在所有病例中考虑辅助放射治疗。
{"title":"Recurrent cerebellar liponeurocytoma with anaplastic features at initial presentation: A case report.","authors":"M. Maharaj, S. Tawfik, F. Ziad, T. Muthu","doi":"10.5414/NP301403","DOIUrl":"https://doi.org/10.5414/NP301403","url":null,"abstract":"BACKGROUND\u0000Cerebellar liponeurocytoma is a rare entity with fewer than 100 reported cases and series in the available literature to date. Although the cerebellum remains the typical primary site, the entity has been shown to demonstrate increased aggressiveness and malignant progression with multiple recurrences.\u0000\u0000\u0000CASE DESCRIPTION\u0000We present a unique case in a 64-year-old gentleman of a cerebellar liponeurocytoma with multiple recurrences and progressive anaplasia. The tumor showed anaplastic features at first presentation and recurred in a more aggressive fashion in a short 2-year period despite surgical debulking and post-operative radiotherapy. It re-recurred within 6 months with subsequent re-debulking without further radiotherapy. At latest follow-up almost 3 years since surgical management of the patient's second recurrence, the patient remains well with minimal neurological impairment and no radiological signs of recurrence.\u0000\u0000\u0000CONCLUSION\u0000Cerebellar liponeurocytoma may present with increasingly atypical histological features that may warrant more aggressive post-operative treatment to prevent disease recurrence and clinical deterioration. This may include a more aggressive surgical resection margin and consideration of adjuvant radiotherapy in all cases.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46254024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prolonged central motor conduction time and pyramidal tract degeneration in amyotrophic lateral sclerosis. 肌萎缩性侧索硬化症中枢性运动传导时间延长与锥体束变性。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-03-28 DOI: 10.5414/NP301438
T. Takeda, M. Iijima, M. Seki, Eiko Higuchi, Yuko Shimizu, N. Shibata, K. Kitagawa
Electrophysiological methods to detect the degeneration of the upper motor neuron system have not been fully established in patients with amyotrophic lateral sclerosis (ALS). This may be partly because the parallel demonstration of electrophysiology and a corresponding pathological abnormality is insufficient, and because a substantial number of patients with ALS do not exhibit upper motor neuron degeneration. Recently, we encountered 2 patients with ALS who had been examined for abnormal central motor conduction time (CMCT) using transcranial magnetic stimulation within a 20-day period prior to their death. Autopsy revealed that 1 patient had marked pyramidal degeneration with prolonged CMCT; in contrast, the other patient had no obvious pyramidal degeneration and showed normal CMCT. Both the patients with contrasting clinicopathological differences contributed to the identification that the prolongation of CMCT was possibly linked to the degeneration of the corticospinal tract. This report indicates that CMCT is useful for predicting the severity of upper motor neuron degeneration in patients with ALS.
在肌萎缩性侧索硬化症(ALS)患者中检测上运动神经元系统退化的电生理方法尚未完全建立。这可能部分是因为电生理和相应病理异常的平行证明是不够的,而且因为相当数量的ALS患者没有表现出上运动神经元变性。最近,我们遇到了2例ALS患者,他们在死亡前20天内使用经颅磁刺激检查中枢运动传导时间(CMCT)异常。尸检显示1例患者有明显的锥体变性,延长CMCT;另1例无明显锥体退变,CMCT正常。这两例患者的临床病理差异不同,有助于确定CMCT的延长可能与皮质脊髓束变性有关。本报告表明CMCT可用于预测ALS患者上运动神经元退化的严重程度。
{"title":"Prolonged central motor conduction time and pyramidal tract degeneration in amyotrophic lateral sclerosis.","authors":"T. Takeda, M. Iijima, M. Seki, Eiko Higuchi, Yuko Shimizu, N. Shibata, K. Kitagawa","doi":"10.5414/NP301438","DOIUrl":"https://doi.org/10.5414/NP301438","url":null,"abstract":"Electrophysiological methods to detect the degeneration of the upper motor neuron system have not been fully established in patients with amyotrophic lateral sclerosis (ALS). This may be partly because the parallel demonstration of electrophysiology and a corresponding pathological abnormality is insufficient, and because a substantial number of patients with ALS do not exhibit upper motor neuron degeneration. Recently, we encountered 2 patients with ALS who had been examined for abnormal central motor conduction time (CMCT) using transcranial magnetic stimulation within a 20-day period prior to their death. Autopsy revealed that 1 patient had marked pyramidal degeneration with prolonged CMCT; in contrast, the other patient had no obvious pyramidal degeneration and showed normal CMCT. Both the patients with contrasting clinicopathological differences contributed to the identification that the prolongation of CMCT was possibly linked to the degeneration of the corticospinal tract. This report indicates that CMCT is useful for predicting the severity of upper motor neuron degeneration in patients with ALS.","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":"1 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70972760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histologically heterogeneous pediatric glioneuronal tumor with FGFR1::TACC1 fusion. FGFR1::TACC1融合的组织学异质性儿童胶质神经元肿瘤。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-03-28 DOI: 10.5414/NP301461
F. Canan, Elena V Daoud, J. Weon, J. Raisanen, D. Burns, K. Hatanpaa, Jason Y. Park, S. Kelley, V. Rajaram
{"title":"Histologically heterogeneous pediatric glioneuronal tumor with FGFR1::TACC1 fusion.","authors":"F. Canan, Elena V Daoud, J. Weon, J. Raisanen, D. Burns, K. Hatanpaa, Jason Y. Park, S. Kelley, V. Rajaram","doi":"10.5414/NP301461","DOIUrl":"https://doi.org/10.5414/NP301461","url":null,"abstract":"","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48848210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypothyroidism combined with anti-signal recognition particle immune-mediated necrotizing myopathy: A case report and review of the literature. 甲状腺功能减退合并抗信号识别粒子免疫介导的坏死性肌病1例报告及文献复习。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-03-01 DOI: 10.5414/NP301434
Jiaying Shi, Huaxing Meng, Wei Zhang, Junhong Guo

Immune-mediated necrotizing myopathy (IMNM) is characterized by proximal limb weakness, elevated creatine kinase (CK) levels, and myofiber necrosis without or with only a small amount of inflammatory cell infiltrate. There is only 1 report of hypothyroidism combined with antibody-negative IMNM to date. We aimed to describe a rare case of hypothyroidism combined with anti-signal recognition particle (SRP) IMNM for the first time and review the previous literature. A 50-year-old male, who had a 4-year history of hypothyroidism treated with levothyroxine replacement therapy, presented with progressive symmetrical proximal muscle weakness. Laboratory testing showed an elevated CK level of 6,106 U/L. Electrophysiological examination elicited carpal tunnel syndrome and myogenic damage. Muscle MRI revealed diffuse abnormal signals in both lower limbs. Given that muscle symptoms are widely recognized among hypothyroid patients, hypothyroid myopathy was initially suspected, and thyroid hormone tablets were added for a week. However, muscle weakness persisted along with an even higher CK (7,020 U/L). Quadriceps muscle biopsy was performed and indicated inflammatory myopathy. Myositis specific antibodies (MSAs) detection revealed that anti-SRP was positive. A diagnosis of hypothyroidism combined with anti-SRP IMNM was finally made. Treatment of corticosteroid and immunosuppressive agents achieved a positive clinical and biochemical response. This case indicates that hypothyroidism combined with anti-SRP IMNM is a rare clinical entity, possibly caused by a general immunologic dysregulation.

免疫介导的坏死性肌病(IMNM)的特征是肢体近端无力,肌酸激酶(CK)水平升高,肌纤维坏死,没有或只有少量炎症细胞浸润。迄今为止,仅有1例甲状腺功能减退合并抗体阴性IMNM的报道。我们首次报道一例罕见的甲状腺功能减退合并抗信号识别颗粒(SRP) IMNM,并回顾以往的文献。50岁男性,有4年甲状腺功能减退病史,经左甲状腺素替代治疗,表现为进行性对称性近端肌无力。实验室检测显示CK水平升高6106 U/L。电生理检查提示腕管综合征和肌源性损伤。肌肉MRI显示双下肢弥漫性异常信号。鉴于肌肉症状在甲状腺功能减退患者中普遍存在,最初怀疑为甲状腺功能减退肌病,并给予甲状腺激素片治疗一周。然而,肌肉无力持续随着更高的CK (7020 U/L)。进行了股四头肌活检,显示炎症性肌病。肌炎特异性抗体(MSAs)检测显示抗srp阳性。最终诊断为甲状腺功能减退合并抗srp IMNM。皮质类固醇和免疫抑制剂治疗取得了积极的临床和生化反应。本病例提示甲状腺功能减退合并抗srp IMNM是一种罕见的临床实体,可能由普遍的免疫失调引起。
{"title":"Hypothyroidism combined with anti-signal recognition particle immune-mediated necrotizing myopathy: A case report and review of the literature.","authors":"Jiaying Shi,&nbsp;Huaxing Meng,&nbsp;Wei Zhang,&nbsp;Junhong Guo","doi":"10.5414/NP301434","DOIUrl":"https://doi.org/10.5414/NP301434","url":null,"abstract":"<p><p>Immune-mediated necrotizing myopathy (IMNM) is characterized by proximal limb weakness, elevated creatine kinase (CK) levels, and myofiber necrosis without or with only a small amount of inflammatory cell infiltrate. There is only 1 report of hypothyroidism combined with antibody-negative IMNM to date. We aimed to describe a rare case of hypothyroidism combined with anti-signal recognition particle (SRP) IMNM for the first time and review the previous literature. A 50-year-old male, who had a 4-year history of hypothyroidism treated with levothyroxine replacement therapy, presented with progressive symmetrical proximal muscle weakness. Laboratory testing showed an elevated CK level of 6,106 U/L. Electrophysiological examination elicited carpal tunnel syndrome and myogenic damage. Muscle MRI revealed diffuse abnormal signals in both lower limbs. Given that muscle symptoms are widely recognized among hypothyroid patients, hypothyroid myopathy was initially suspected, and thyroid hormone tablets were added for a week. However, muscle weakness persisted along with an even higher CK (7,020 U/L). Quadriceps muscle biopsy was performed and indicated inflammatory myopathy. Myositis specific antibodies (MSAs) detection revealed that anti-SRP was positive. A diagnosis of hypothyroidism combined with anti-SRP IMNM was finally made. Treatment of corticosteroid and immunosuppressive agents achieved a positive clinical and biochemical response. This case indicates that hypothyroidism combined with anti-SRP IMNM is a rare clinical entity, possibly caused by a general immunologic dysregulation.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":"41 2","pages":"83-88"},"PeriodicalIF":1.1,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39686635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cerebral amyloidomas: Perspective on unusual morphological features. 脑淀粉样瘤:异常形态学特征的透视。
IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY Pub Date : 2022-03-01 DOI: 10.5414/NP301440
Bette K Kleinschmidt-DeMasters

Aims: Cerebral amyloidomas (CAs) are mass-producing congophilic lesions most commonly due to λ light chain deposits, contrasting them with light chain deposition disease (LCDD) which has non-polarizable, often κ light chain deposition.

Materials and methods: Although usual histological features are well known, we detail 3 recent CAs with unusual morphological findings and review the literature specifically for these features.

Results: Two women, aged 56 and 58 years, had right cerebral white matter CAs. The biopsy of case 1 disclosed congophilic polarizable deposits with prominent dystrophic mineralization as well as scant plasma cells. Case 2 had a CA with significant multinucleated giant cell reaction to the amyloid and additionally contained an area suspicious for marginal zone B-cell lymphoma. Case 3 was a clinically unsuspected CA identified at autopsy in a 75-year-old woman that manifested as several contiguous left frontal lobe white matter erythematous, hyperemic lesions; microscopy showed nodular and concentric amyloid deposits and thick perivascular cuffs of plasma cells. Mass spectrometry proved λ light and α heavy chain amyloid deposits in all 3 cases.

Conclusion: These 3 CA cases illustrate several unusual gross and microscopic features that are discussed in context with the literature.

目的:脑淀粉样瘤(CAs)是一种大量产生的嗜嗜性病变,最常见的原因是λ轻链沉积,与轻链沉积病(LCDD)相比,后者具有非极化的,通常是κ轻链沉积。材料和方法:虽然通常的组织学特征是众所周知的,但我们详细介绍了最近3例具有不同寻常形态学发现的ca,并专门针对这些特征回顾了文献。结果:2例女性,年龄56岁和58岁,右侧脑白质癌。病例1的活检显示嗜嗜性极化沉积物伴显著的营养不良矿化和浆细胞缺失。病例2的CA伴明显的多核巨细胞对淀粉样蛋白的反应,另外包含一个可疑的边缘带b细胞淋巴瘤区域。病例3是一名75岁女性在尸检中发现的临床未怀疑的CA,表现为几个连续的左额叶白质红斑,充血病变;镜检显示结节状和同心淀粉样蛋白沉积,浆细胞周围有厚的血管袖口。质谱分析证实3例患者均有λ轻链和α重链淀粉样蛋白沉积。结论:这3例CA病例说明了几种不寻常的大体和显微镜特征,并在文献中进行了讨论。
{"title":"Cerebral amyloidomas: Perspective on unusual morphological features.","authors":"Bette K Kleinschmidt-DeMasters","doi":"10.5414/NP301440","DOIUrl":"https://doi.org/10.5414/NP301440","url":null,"abstract":"<p><strong>Aims: </strong>Cerebral amyloidomas (CAs) are mass-producing congophilic lesions most commonly due to λ light chain deposits, contrasting them with light chain deposition disease (LCDD) which has non-polarizable, often κ light chain deposition.</p><p><strong>Materials and methods: </strong>Although usual histological features are well known, we detail 3 recent CAs with unusual morphological findings and review the literature specifically for these features.</p><p><strong>Results: </strong>Two women, aged 56 and 58 years, had right cerebral white matter CAs. The biopsy of case 1 disclosed congophilic polarizable deposits with prominent dystrophic mineralization as well as scant plasma cells. Case 2 had a CA with significant multinucleated giant cell reaction to the amyloid and additionally contained an area suspicious for marginal zone B-cell lymphoma. Case 3 was a clinically unsuspected CA identified at autopsy in a 75-year-old woman that manifested as several contiguous left frontal lobe white matter erythematous, hyperemic lesions; microscopy showed nodular and concentric amyloid deposits and thick perivascular cuffs of plasma cells. Mass spectrometry proved λ light and α heavy chain amyloid deposits in all 3 cases.</p><p><strong>Conclusion: </strong>These 3 CA cases illustrate several unusual gross and microscopic features that are discussed in context with the literature.</p>","PeriodicalId":55251,"journal":{"name":"Clinical Neuropathology","volume":"41 2","pages":"46-52"},"PeriodicalIF":1.1,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39766178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Neuropathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1